Pharmaceutical Industry Blog

Isatuximab is a monoclonal antibody designed to treat multiple myeloma, a type of blood cancer that affects plasma cells in the bone...

Introduction : Deruxtecan is a novel topoisomerase I inhibitor that has shown significant promise in the treatment of various cancers. As...

Anselamimab is an innovative monoclonal antibody designed to treat autoimmune diseases. By targeting specific immune cells, anselamimab...

Introduction : Trastuzumab is a groundbreaking monoclonal antibody that has revolutionized the treatment landscape for HER2-positive...

Gemtuzumab ozogamicin is an antibody-drug conjugate designed to treat acute myeloid leukemia (AML). This innovative therapy targets...

Epcoritamab is a monoclonal antibody designed to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell...